Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02890069
Title A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DEU

Facility Status City State Zip Country Details
UCLA Santa Monica Hematology / Oncology SC Santa Monica California 90404 United States Details
Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21231 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
The Regents of the University of Michigan Ann Arbor Michigan 48109 United States Details
Washington University Medical School SC Saint Louis Missouri 63110 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
UT Health San Antonio Mays Cancer Center San Antonio Texas 78229 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Seattle Cancer Care Alliance Seattle Washington 98105 United States Details
Novartis Investigative Site Jena 07740 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Wuerzburg 97080 Germany Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Leiden 2300 RC Netherlands Details
Novartis Investigative Site Rotterdam 3075 EA Netherlands Details
Novartis Investigative Site Utrecht 3584CX Netherlands Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Pamplona Navarra 31008 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Sutton Surrey SM2 5PT United Kingdom Details
Novartis Investigative Site Manchester M20 4BX United Kingdom Details
Novartis Investigative Site Oxford OX3 7LJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field